Health Information Management

Advisory panel speaks out against proposed decrease in separately payable drug reimbursement for 2009

Briefings on APCs, December 1, 2008

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on APCs.

One of the more controversial provisions of the 2009 OPPS proposed rule is CMS’ plan to reduce drug reimbursement for separately payable drugs from the current average sales price (ASP) plus 5% to ASP plus 4%.

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on APCs.

Comments

0 comments on “Advisory panel speaks out against proposed decrease in separately payable drug reimbursement for 2009

 

Most Popular